Announcement on Subsidiary's Withdrawal of Drug Registration Application
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Subsidiary's Withdrawal of Drug Registration Application
Filed with SSE · · 3 pages · Chinese
Release
North China Pharmaceutical Company Ltd. on 6ix
Later from North China Pharmaceutical
- Announcement on Receiving the Return of Income from Government Land Purchase, Reserve and Transfer and Signing the Supplementary Contract for Acquisition (Return) of State-owned Land Use Rights of Enterprises and Institutions
- Announcement on Expected Increase in Annual Performance for 2024
- Announcement on the Wholly-owned Subsidiary's Passing GMP Compliance Inspection
- Announcement on the Wholly-owned Subsidiary's Acquisition of the GMP Compliance Certificate Issued by AEMPS of Spain
- Announcement on Change of Accounting Policies
Follow North China Pharmaceutical into a list and get an email when it puts out news.
Follow North China Pharmaceutical